Llwytho...
Retained products of conception in hysteroscopy in a patient with breast cancer on tamoxifen
Tamoxifen is a selective oestrogen receptor modulator widely used in breast cancer treatment, with good survival rates. Its partial agonist action on other tissues such as the uterus, however, promotes the development of endometrial hyperplasia and cancer. It appears that tamoxifen does not alter th...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMJ Case Rep |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721742/ https://ncbi.nlm.nih.gov/pubmed/31473640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230635 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|